Skip to main content
. 2017 Nov 23;153(5):1240–1248. doi: 10.1016/j.chest.2017.11.017

Figure 5.

Figure 5

Estimated lung density decline (adjusted lung density at 15th percentile at total lung capacity) over 48 months, using data from the mixed-effects regression model applied to each trial separately (the Randomized, Placebo-Controlled Trial of Augmentation Therapy in Alpha-1 Proteinase Inhibitor Deficiency [RAPID-RCT] and RAPID Open Label Extension [RAPID-OLE] trial intention-to-treat population).